Holen Sie sich die Stockscreener-App
6.38
11.14%
-0.80
Handel nachbörslich:
6.38
Finanzdaten der Emergent Biosolutions Inc-Aktie (EBS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
50.10%
234.30
|
156.10 | 148.70 | 231.10 | 140.90 |
| Cost Of Revenue |
34.86%
97.10
|
72.00 | 84.90 | 85.90 | 66.90 |
Selling, General, and Administrative
|
4.29%
44.60
|
46.60 | - | - | - |
| Operating Income/Loss |
1,291%
-125.10
|
10.50 | -27.90 | 76.50 | 1.60 |
| Nonoperating Income/Loss |
1,521%
-41.20
|
2.90 | -22.80 | -18.90 | -18.40 |
| Income/Loss From Continuing Operations Before Tax |
1,341%
-166.30
|
13.40 | -50.70 | 57.60 | -16.80 |
| Income Tax Expense/Benefit |
110.61%
13.90
|
6.60 | 3.90 | 6.40 | -4.80 |
| Net Income/Loss |
2,750%
-180.20
|
6.80 | -54.60 | 51.20 | -12.00 |
| Basic Average Shares |
0.58%
51.60
|
51.90 | -0.40 | 53.20 | 54.20 |
| Diluted Average Shares |
8.67%
51.60
|
56.50 | - | 56.50 | 54.20 |
| Basic Earnings Per Share |
2,785%
-3.49
|
0.13 | -1.01 | 0.96 | -0.22 |
| Diluted Earnings Per Share |
5,086%
-3.49
|
0.07 | -0.96 | 0.91 | -0.22 |
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):